0
Special Feature |

Pathological Case of the Month FREE

[+] Author Affiliations

Section Editor: Enid Gilbert-barness, MD

More Author Information
Arch Pediatr Adolesc Med. 2001;155(6):738. doi:10.1001/archpedi.155.6.737.
Text Size: A A A
Published online

DIAGNOSIS AND DISCUSSION: PULMONARY MICROVASCULAR PLATELET THROMBOSIS

Figure 1. Computed tomographic scan of the head shows a subcutaneous dense soft tissue massive lesion with calcification (hemangioma).

Figure 2. The section of subcutaneous lesion of the head reveals proliferation of endothelial-lined blood vessels separated by scanty stroma and areas of hemorrhage.

Figure 3. The section of the lung shows small vessels containing intravascular basophilic granular thrombi.

Figure 4. The section of the lung reveals positive immunohistochemical staining for platelet factor VIII of intravascular basophilic granular thrombi (platelet thrombi).

Microvascular platelet thrombosis is an uncommon condition. In several diseases, it is presumed to result in endothelial cell damage or dysfunction; intravascular coagulation plays an important pathogenic role. These disorders include thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. The features of this disorder are the apparent selective consumption of platelets, usually without accompanying coagulation abnormalities, and the predominance of platelets as the occlusive material in the microvessels.1 The organ systems with a high incidence of microvascular thrombosis associated with subsequent end-organ dysfunction include lungs, renal, central nervous system, liver, adrenal glands, and heart. Microvascular platelet thrombosis is often easily demonstrated in the pulmonary microcirculation, where it is customarily seen in association with intense vasoconstriction resulting from vasoconstrictive compounds released from platelets, including biogenic amines, adenine nucleotides, and kinins.2 The presence of platelet microthrombi is also an early finding in patients with disseminated intravascular coagulation. The early deposited platelet-rich microthrombi are later replaced by fibrin-rich hyaline microthrombi.3 The microscopic study of the lungs in our case showed the small vessels filled with platelet thrombi that were confirmed by factor VIII stain. Moreover, these thrombi were negative for fibrin stain. These observations suggest the possibility of selective consumption of platelet or early stage of disseminated intravascular coagulation. Several mechanisms of pathologic platelet aggregation have been proposed. The presence of a platelet-agglutinating protein in the plasma in the thrombotic thrombocytopenic purpura is postulated.4 On the other hand, von Willebrand factor multimers in the blood and their involvement in the excessive and inappropriate agglutination of platelets have been suggested.5 In our case, it is apparent that a multifactorial process resulted in the intraluminal platelet thrombus formation. The surgical resection of massive hemangioma may be associated with the release of platelet-agglutinating protein and/or von Willebrand factor multimers from damaged endothelial cells into the systemic circulation. It has been known that intravascular hemolysis of any origin is a common triggering event for disseminated intravascular coagulation. During hemolysis, the release of red blood cell adenosine diphosphate and/or red blood cell membrane phospholipoprotein may activate the procoagulant system.2,6

This infant had reportedly lost a substantial amount of blood during surgery and received multiple transfusions with the banked red blood cells over a short period. Intravascular hemolysis resulting from a massive transfusion, even a minor hemolytic transfusion reaction with release of red blood cell adenosine diphosphate or red blood cell membrane phospholipoprotein, can provide a trigger for activation of an episode of acute disseminated intravascular coagulation. The diffuse pulmonary intraluminal platelet thrombus formation resulted in the organ ischemia and hypoxia rather than end-organ hemorrhage, which most likely contributed to cardiopulmonary arrest of this patient toward the end of the surgical procedure.

Accepted for publication May 24, 1999.

Reprints: Sunita Chandra, MD, University of Wisconsin Hospital and Clinics, 600 Highland Ave, University of Wisconsin, Madison, WI 53792.

Neame  PBLechago  JLing  ETKoval  A Thrombotic thrombocytopenic purpura: report of a case with disseminated intravascular platelet aggregation. Blood. 1973;42805- 814
Bick  RL Disseminated intravascular coagulation and related syndromes: a clinical review. Semin Thromb Hemost. 1988;14299- 338
Boyd  JF Disseminated fibrin-thromboembolism among neonates dying within 48 hours of birth. Arch Dis Child. 1967;42401- 409
Siddiqui  FALian  EC Novel platelet-agglutinating protein from thrombotic thrombocytopenic purpura plasma. J Clin Invest. 1985;761330- 1337
Moake  JLRudy  CKTroll  JH  et al.  Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982;3071432- 1435
Surgenor  DM Erythrocytes and blood coagulation. Thromb Diath Haemorrh. 1974;32247- 259

Tables

References

Neame  PBLechago  JLing  ETKoval  A Thrombotic thrombocytopenic purpura: report of a case with disseminated intravascular platelet aggregation. Blood. 1973;42805- 814
Bick  RL Disseminated intravascular coagulation and related syndromes: a clinical review. Semin Thromb Hemost. 1988;14299- 338
Boyd  JF Disseminated fibrin-thromboembolism among neonates dying within 48 hours of birth. Arch Dis Child. 1967;42401- 409
Siddiqui  FALian  EC Novel platelet-agglutinating protein from thrombotic thrombocytopenic purpura plasma. J Clin Invest. 1985;761330- 1337
Moake  JLRudy  CKTroll  JH  et al.  Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982;3071432- 1435
Surgenor  DM Erythrocytes and blood coagulation. Thromb Diath Haemorrh. 1974;32247- 259

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles